Does RITLECITINIB Cause Disease recurrence? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Disease recurrence have been filed in association with RITLECITINIB (Litfulo). This represents 0.4% of all adverse event reports for RITLECITINIB.
6
Reports of Disease recurrence with RITLECITINIB
0.4%
of all RITLECITINIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Disease recurrence From RITLECITINIB?
Of the 6 reports.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITLECITINIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RITLECITINIB Cause?
Drug ineffective (259)
Therapeutic product effect incomplete (122)
Condition aggravated (85)
Off label use (82)
Headache (70)
Diarrhoea (49)
Product dose omission issue (45)
Alopecia (44)
Fatigue (36)
Urticaria (36)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which RITLECITINIB Alternatives Have Lower Disease recurrence Risk?
RITLECITINIB vs RITODRINE
RITLECITINIB vs RITONAVIR
RITLECITINIB vs RITUXAN
RITLECITINIB vs RITUXIMAB
RITLECITINIB vs RITUXIMAB-ABBS